News, Press Release
TheWell Bioscience Launches RocketCell™ Cell Viability Enhancer to Maximize Cell Recovery, Survival, and Growth for Stem Cell and Organoid Research
Proprietary small-molecule cocktail significantly improves post-passaging recovery, cryopreservation outcomes, and long-term expansion of sensitive cell cultures.
MONMOUTH JUNCTION, N.J., July7, 2026 — TheWell Bioscience, a leader in xeno-free 3D cell culture technologies, today announced the commercial launch of RocketCell™ Cell Viability Enhancer, a proprietary small-molecule formulation designed to maximize cell survival, metabolic recovery, and growth following passaging, thawing, and cryopreservation.
Developed for sensitive cell types, including induced pluripotent stem cells (iPSCs), neural stem cells (NSCs), organoids, and other iPSC-derived cultures, RocketCell™ Cell Viability Enhancer helps researchers overcome one of the most persistent challenges in advanced cell culture—cell stress and loss during routine handling.
Unlike conventional ROCK inhibitors that primarily reduce dissociation-induced apoptosis, RocketCell™ Cell Viability Enhancer combines a potent ROCK inhibitor with proprietary secondary metabolic stabilizers that actively support cellular recovery, promote rapid cell-cycle re-entry, and accelerate colony formation following stressful procedures.
“Researchers invest significant time and resources developing valuable cell models, yet many still experience substantial losses after passaging or thawing,” said John Huang Ph.D., CEO of TheWell Bioscience. “RocketCell™ Cell Viability Enhancer was developed to do more than simply improve survival. It helps cells recover metabolically, resume proliferation more rapidly, and generate healthier cultures, allowing researchers to spend less time recovering cells and more time generating meaningful data.”
Designed for Modern Cell Culture Workflows
RocketCell™ Cell Viability Enhancer is optimized for multiple critical workflow steps, including:
- Single-cell passaging
- Routine subculturing
- Recovery following enzymatic dissociation
- Cryopreservation and post-thaw recovery
- Organoid harvesting and re-seeding
- Both 2D and 3D culture systems
The reagent integrates seamlessly with TheWell Bioscience’s expanding RocketCell™ xeno-free media portfolio while remaining compatible with a broad range of existing stem cell and organoid culture workflows.
Demonstrated Performance Beyond Traditional ROCK Inhibitors
Internal validation studies demonstrate that RocketCell™ Cell Viability Enhancer delivers:
- Superior post-passaging growth kinetics compared to commonly used ROCK inhibitors, including Y-27632 and Thiazovivin (TZV)
- Enhanced metabolic recovery following dissociation-induced stress
- Improved plating efficiency and colony formation
- Higher organoid recovery and expansion after harvesting
- Improved survival during cryopreservation and thawing
Studies using both mouse intestinal organoids and colon organoids showed significantly greater recovery and growth when RocketCell™ Cell Viability Enhancer was incorporated into harvesting and early culture workflows. The strongest performance was observed when the enhancer was used throughout the harvesting process and maintained during the first 24–48 hours of recovery, providing additional protection against harvesting-induced cellular stress.
A Critical Component of TheWell Bioscience’s Xeno-Free Ecosystem
RocketCell™ Cell Viability Enhancer is an integral component of TheWell Bioscience’s comprehensive xeno-free platform, supporting reproducible workflows from cell recovery through long-term expansion. It is also included within the RocketCell™ 3D iPSC Xeno-Free Complete Growth Kit, providing enhanced recovery following 3D passaging and cryopreservation.
By combining defined media, synthetic extracellular matrices, growth factors, cultureware, and specialized workflow reagents, TheWell Bioscience enables researchers to transition from traditional animal-derived systems toward fully defined, scalable, and reproducible cell culture platforms.
About TheWell Bioscience Inc.
TheWell Bioscience is a biotechnology company delivering an end-to-end xeno-free platform for robust and reproducible 3D cell models. Its integrated ecosystem includes VitroGel® hydrogels, RocketCell™ media, VitroPrime™ cultureware, CytoGrow™ growth factors, and Cyto3D® reagents. By eliminating animal-derived variability, the company provides defined, scalable solutions supporting organoid research, precision medicine, cell therapy, biomanufacturing, and New Approach Methodologies (NAMs).
TheWell Bioscience Inc.:
Tel: +1 973-855-4955
E-mail: [email protected]
Discover how our end-to-end platform can support your cell culture research
Explore our updated resources for a concise overview of VitroGel®’s key features and application areas.
Comparison of VitroGel® vs. Animal-based ECM
Discover the 20+ advantages of VitroGel® over animal-based ECM with this comprehensive comparison on key features, operation, application, and storage conditions.
Learn More
What is VitroGel® | Overview Video
Learn why VitroGel® is the leading animal-free hydrogel for 3D cell culture.
Learn More
End-to-end Platform for Organoid Culture
Learn about our solutions for consistent and robust organoid culture.
Learn More